Author:
Kelly C. P.,England R. E.,McDonald G. S. A.,Weir D. G.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Roba, J., Claeys, M., Lambelin, G. Antiplatelet and antithrombogenio effects of suloctidil. Eur. J. Pharmacol. 1976: 37, 265–74.
2. Roba, J., Reuse, S., Lambelin, G.In vivo antispasmodic activity of suloctidil. Arch. Int. Pharm. Ther. 1976: 221, 54–59.
3. De Gaetano, G., Miragliotta, G., Roncucci, R., Lansen, J., Lambelin, G. Suloctidil; a novel inhibitor of platelet aggregation in human beings. Thrombosis Research 1976: 8, 361–71.
4. Gurewich, V., Lipinski, B. Evaluation of the antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole. Thrombosis Research 1976: 9, 101–08.
5. Schouten, J. A., Westerman, R. F. Elevated liver enzymes in serum during suloctidil treatment. Eur J. Clin. Pharmacol. 1982: 22, 559–60.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献